Anti-tumour activity of four soy isoflavone components against Src-activated human adenocarcinoma cells by Ono, Misaki et al.
Trends in Natural Product Research – PSE Young Scientists’ Meeting 






Anti-tumour activity of four soy isoflavone components against  
Src-activated human adenocarcinoma cells 
 
Misaki Ono1, Takako Higuchi1, Mikako Takeshima1 and Shuji Nakano1,2 
 
1 Department of Nutritional Sciences Faculty of Health and Nutritional Sciences, Nakamura Gakuen University, 
Fukuoka, Japan. 
2 Graduate School of Health and Nutritional Sciences, Nakamura Gakuen University, Fukuoka, Japan. 
 
*E-mail: mono@nakamura-u.ac.jp  
 
Src oncogene has been strongly implicated in the development, growth, progression, 
and metastasis of a variety of human cancers [1]. Genistein (GEN), a natural 
isoflavonoid phytoestrogen, is a strong inhibitor of Src [2]. Although daidzein, glycitein 
and equol, a metabolite of daidzein, are also major soy Isoflavone components, their 
functional role in Src activity remains unknown. Using HAG-1 human adenocarcinoma 
cells transfected with v-src (HAG/src), we investigated the anti-tumour activity of four 
isoflavone components by measuring proliferation, apoptosis, cell cycle perturbation, 
and signal proteins with WST-1 assay, FACS analyses, and Western blot, respectively.  
Activation of Src conferred resistance to either daidzein, glycitein or equol, but 
rendered the cells more sensitive to GEN. GEN arrested HAG/src cells at G2/M phase, 
while other isoflavones could not arrest HAG/src cells at any phase of the cell cycle. 
The sub-G0/G1 apoptotic cell populations were not increased over 72h exposure with 
either isoflavone components. GEN increased the expression levels of p53 and p21 
with decreased phosphorylated p21. The levels of other main cell cycle-related 
proteins were not affected. These data suggest that GEN would be the only isoflavone 
component that may potentially suppress oncogenic activity driven by Src through 
increasing p53 and p21 levels. 
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